表紙:先進創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1309222

先進創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

Advanced Wound Care Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Wound Type, By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)

出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

先進創傷治療市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の先進創傷治療市場は予測期間中に目覚ましい成長を遂げると予測されています。

市場成長の要因としては、世界中で慢性疾患の頻度が上昇し、高度な創傷ケアソリューションの需要が高まっていることが挙げられます。さらに、高齢者は治癒能力が鈍いため、老人人口の増加が市場拡大の原動力になると予測されています。例えば、WHOの推計によると、60歳以上の成人の割合は2017年には9.8%であり、2030年には13.7%、2050年には20.3%にそれぞれ上昇します。同様に、米国の一般人口層で現在最も急速に増加しているのは高齢者(65歳以上)です。米国国勢調査局による全国人口予測によると、2060年までに米国人の4人に1人が高齢者になると予測されており、これが市場成長の原動力になると予想されています。

世界の糖尿病患者の増加

糖尿病患者は頻繁に糖尿病性足潰瘍を発症するが、これは高度な創傷ケアソリューションを用いて治療することができます。例えば、ScienceDirectによると、糖尿病性足潰瘍を発症した患者の20%は足の切断が必要になる可能性があります。糖尿病性足潰瘍は糖尿病人口の25%以上に影響を及ぼす可能性があります。その結果、より多くの糖尿病患者が洗練された創傷ケアソリューションを採用するようになると予測されています。これらの製品は保湿を助け、内傷と外傷の両方を早く治すことができます。さらに、WHOによると、世界では合計4億2,200万人が糖尿病を患っており、その大半は低・中所得国に居住しています。糖尿病は年間150万人の死亡原因となっています。過去数十年にわたり、糖尿病の罹患率と有病率は一貫して上昇しており、これが市場の成長を促進すると予想されています。

慢性疾患有病率の上昇

慢性疾患の有病率は手術を伴うため、慢性疾患有病率の上昇が世界の先進創傷治療市場の成長の原因となっています。したがって、手術件数の増加が先進創傷治療管理への需要を促進しています。すべての国の成人の死因のトップは慢性疾患/非伝染性疾患であり、今後10年間でこの数はさらに17%増加すると予想されています。世界中で全人口の3分の1が多くの慢性疾患と闘っています。米国では、10人中4人が2つ以上の慢性疾患を抱えており、成人の10人中6人を占めています。2000年から2030年の間に、慢性疾患を抱えるアメリカ人の数は4,600万人(37%)増加します。このことが市場の成長を押し上げると予想されます。

最近の動向

  • 褥瘡、下腿潰瘍、糖尿病性足潰瘍などの滲出性の高い創傷用の超吸収性ドレッシング材ConvaMaxの発売が、2020年1月のConvaTec社の発表で紹介されました。
  • Integra LifeSciences社は、2020年5月にIntegra Bilayer Wound Matrixの臨床結果が良好であることを発表しました。(IBWM)を発表しました。同社の再生技術のポートフォリオには、コラーゲンと羊水を利用したこの製品も含まれています。

利用可能なカスタマイズ

TechSciリサーチは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です:

企業情報

  • 追加市場参入企業(最大5社)の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

  • 調査目的
  • 別ライン調査手法
  • 主要産業パートナー
  • 主要協会と二次情報源
  • 予測手法
  • データの三角測量と検証
  • 仮定と限界

第3章 エグゼクティブサマリー

  • 市場概要
  • 主要市場セグメンテーションの概要
  • 主要市場プレーヤーの概要
  • 主要地域/国の概要
  • 市場促進要因・課題・動向の概要

第4章 顧客の声

第5章 先進創傷治療の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別(ドレッシング材、グラフト&マトリックス、外用剤、その他)
    • 創傷タイプ別(慢性創傷、急性創傷)
    • エンドユーザー別(病院・診療所、外来診療センター、在宅ケア)
    • 地域別
    • 企業別(2022年)
  • 製品マップ

第6章 北米の先進創傷治療市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の先進創傷治療市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • 英国
    • イタリア
    • ドイツ
    • スペイン

第8章 アジア太平洋の先進創傷治療市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の先進創傷治療市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの先進創傷治療市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 創傷タイプ別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • トルコ
    • エジプト

第11章 市場力学

  • 促進要因
    • 糖尿病の流行に伴う人口の増加。
    • 世界の外科手術の増加
    • 世界の慢性疾患の増加
  • 課題
    • 高度な創傷ケア製品の高価格
    • 限られた医療労働力
    • 予測不可能で予見不可能な活動

第12章 市場動向と発展

  • 製品上市
  • 合併と買収
  • 技術の進歩

第13章 先進創傷治療の世界市場SWOT分析

第14章 競合情勢

  • Kimberly-Clark Corporation
    • Business Overview
    • Product Offerings
    • Recent Developments
    • Financials(In Case of Listed Companies)
    • Key Personnel
    • SWOT Analysis
  • Abbott Nutrition
  • Boston Scientific Corporation
  • Amsino International Inc.
  • ConMed Corporation
  • Moog Inc
  • C.R.Bard
  • Danone
  • Cook Medical
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Cardinal Health Inc.

第15章 戦略的提言

目次
Product Code: 14955

Global Advanced Wound Care Market is projected to witness impressive growth during the forecast period. The factors contributing to the growth of the market are the rising frequency of chronic diseases around the world while driving the demand for sophisticated wound care solutions. Additionally, as the older population has sluggish healing capacities, the growing geriatric population is anticipated to drive market expansion. For instance, the WHO estimates that the percentage of adults 60 or older was 9.8% in 2017 and will rise to 13.7% and 20.3%, respectively, in 2030 and 2050. Similarly, the U.S. general population's fastest-growing demographic is currently seniors (aged 65 and over). One in four Americans are predicted to be older adults by 2060, according to the National Population Projections by the U.S. Census Bureau, which is anticipated to drive market growth.

Furthermore, the market for advanced wound care is anticipated to be significantly impacted by technological developments in advanced wound care products. It is anticipated that some of the most cutting-edge technological goods in this area will soon enter the market. For instance, bioactive molecules across the treated area, which maintain the drug release and specifically enhance the therapeutic effects of pharmaceuticals, are used in nanoparticle-based wound healing and skin regeneration. Similarly, it is anticipated that gene therapy, which promotes wound healing by infusing healthy normal genes into cells, will start selling. The market for advanced wound care is thus anticipated to grow throughout the projected period because of such developments in advanced wound care products.

Increasing Prevalence of Diabetes globally

Diabetes patients frequently develop diabetic foot ulcers, which can be treated using advanced wound care solutions. For instance, according to ScienceDirect, 20% of individuals who have diabetic foot ulcers may require amputation of the foot. Diabetic foot ulcers may impact more than 25% of the diabetic population. As a result, it is predicted that more diabetic people will adopt sophisticated wound care solutions. These goods aid in the retention of moisture and enable both internal and exterior wounds to heal quickly. Further, as per WHO, a total of 422 million people worldwide have diabetes, the majority of whom reside in low- and middle-income nations. Wherein diabetes is responsible for 1.5 million fatalities annually. Over the past few decades, there has been a consistent rise in both the incidence and prevalence of diabetes, which in turn is expected to drive the growth of the market.

The rise in Chronic Diseases Prevalence

The rise in chronic disease prevalence is responsible for the growth of Global Advanced Wound Care Market, as chronic disease prevalence involves surgeries. Hence, rising surgeries are fueling the demand for advanced wound care management. The leading cause of death for adults in all nations is chronic diseases/non-communicable diseases, and in the coming ten years, this number is expected to rise by another 17%. A third of all people worldwide struggle with numerous chronic conditions. In the US, four out of ten people have two or more chronic diseases, making up six out of ten adults. The number of Americans with chronic diseases will rise by 46 million, or 37 percent, between 2000 and 2030. This factor is expected to boost the growth of the market.

Market Segmentation

The Global Advanced Wound Care Market is segmented based on Product, wound type, and end-user. The product segment is classified into dressings, grafts & matrices, topical agents, and others. Based on wound type, the market is divided into chronic wound and acute wound. Lastly, based on end-user, the market is categorized into hospitals & clinics, ambulatory care centers, and homecare.

Recent Developments

  • The launch of ConvaMax, a superabsorber dressing for highly exuding wounds such as pressure ulcers, leg ulcers, and diabetic foot ulcers, was introduced in an announcement by ConvaTec in January 2020.
  • Integra LifeSciences announced a successful clinical outcome for Integra Bilayer Wound Matrix in May 2020. (IBWM). The company's portfolio of regenerative technologies includes this product, which makes use of collagen and amniotic fluid.

Market players

Abbott Nutrition, Boston Scientific Corporation, Amsino International Inc., ConMed Corporation, Cardinal Health Inc., C.R.Bard, Danone, Cook Medical, B. Braun Melsungen AG, Fresenius SE & Co. KGaA.

Report Scope

In this report, the global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Advanced Wound Care Market, By Product:

  • Dressings
  • Grafts & Matrices
  • Topical Agents
  • Others

Advanced Wound Care Market, By Wound Type:

  • Chronic Wounds
  • Acute Wounds

Advanced Wound Care Market, By End-Use:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Homecare

Advanced Wound Care Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • South Arabia
    • Saudi Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Advanced Wound Care Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 5.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Map

6. North America Advanced Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 6.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 6.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Advanced Wound Care Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Wound Type
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Advanced Wound Care Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Wound Type
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Advanced Wound Care Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Wound Type
        • 6.3.3.2.3. By End-use

7. Europe Advanced Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 7.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 7.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Advanced Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End-use
    • 7.3.2. United Kingdom Advanced Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End-use
    • 7.3.3. Italy Advanced Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End-use
    • 7.3.4. Germany Advanced Wound Care Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Wound Type
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Advanced Wound Care Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Wound Type
        • 7.3.5.2.3. By End-use

8. Asia-Pacific Advanced Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 8.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 8.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Advanced Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Advanced Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Advanced Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Advanced Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Advanced Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End-use

9. South America Advanced Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 9.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 9.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Advanced Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina Advanced Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia Advanced Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End-use

10. Middle East and Africa Advanced Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Dressings, Grafts & Matrices, Topical Agents, Others)
    • 10.2.2. By Wound Type (Chronic Wounds, Acute Wounds)
    • 10.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Advanced Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End-use
    • 10.3.2. UAE Advanced Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End-use
    • 10.3.3. Saudi Arabia Advanced Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End-use
    • 10.3.4. Turkey Advanced Wound Care Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Wound Type
        • 10.3.4.2.3. By End-use
    • 10.3.5. Egypt Advanced Wound Care Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Wound Type
        • 10.3.5.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rise in number of populations along with diabetes prevalence.
    • 11.1.2. Increasing surgical procedures globally
    • 11.1.3. Rise prevalence of chronic diseases across the globe
  • 11.2. Challenges
    • 11.2.1. High cost of advanced wound care products
    • 11.2.2. Limited medical workforce
    • 11.2.3. Unpredictable and unforeseeable activities

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Advanced Wound Care Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Kimberly-Clark Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (In Case of Listed Companies)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Abbott Nutrition
  • 14.3. Boston Scientific Corporation
  • 14.4. Amsino International Inc.
  • 14.5. ConMed Corporation
  • 14.6. Moog Inc
  • 14.7. C.R.Bard
  • 14.8. Danone
  • 14.9. Cook Medical
  • 14.10. B. Braun Melsungen AG
  • 14.11. Fresenius SE & Co. KGaA
  • 14.12. Cardinal Health Inc.

15. Strategic Recommendations